|
Index of reports
> Cases resulting in other serious reactions (706)
> Cases with Breast Cancer Metastatic (228)
Below is the selection of adverse event reports related to Premarin (Conjugated Estrogens) that includes cases resulting in other serious reactions where reactions include breast cancer metastatic.
Reports 1 - 25 of 228 Next >>
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Premarin
Prempro
Dosage: unspecified
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1982-01-01
End date: 2001-01-01
Prempro
Indication: Menopausal Symptoms
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female, weighing 57.7 kg (126.9 pounds)
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Cycrin
Premarin
Prempro
Dosage: not specified
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1990-01-01
End date: 2001-01-01
Prempro
Indication: Menopausal Symptoms
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Cycrin
Dosage: unknown
Indication: Hormone Replacement Therapy
Medroxyprogesterone Acetate
Dosage: unknown
Indication: Hormone Replacement Therapy
Premarin
Premarin
Dosage: unknown
Indication: Oestrogen Replacement Therapy
Prempro
Dosage: unknown
Indication: Hormone Replacement Therapy
Provera
Dosage: unknown
Indication: Hormone Replacement Therapy
Unspecified Estrogen Replacement Therapy
Dosage: unknown
Indication: Oestrogen Replacement Therapy
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Premarin
Prempro / Premphase
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Climara
Premarin
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Estrogen NOS
Premarin
Prempro
Dosage: unspecified
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1984-01-01
End date: 1997-04-01
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Adverse event resulted in: hospitalization
Suspect drug(s):
Estrace
Estradiol
Medroxyprogesterone Acetate
Premarin
Prempro
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Premarin
Prempro / Premphase
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a lawyer from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Cycrin
Indication: Hormone Replacement Therapy
Premarin
Indication: Hormone Replacement Therapy
Prempro
Indication: Hormone Replacement Therapy
Provera
Indication: Hormone Replacement Therapy
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Premarin (Conjugated Estrogens)
Other drugs received by patient: Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-30
Patient: female, weighing 59.0 kg (129.8 pounds)
Adverse reactions / side effects: Breast Cancer Metastatic
Adverse event resulted in: hospitalization
Suspect drug(s):
Estrace
Premarin
Dosage: unknown
Indication: Oestrogen Replacement Therapy
Start date: 1994-01-01
End date: 1996-01-01
Prempro
Dosage: unknown
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1996-01-01
End date: 2002-01-01
Provera
Dosage: unknown
Indication: Hormone Replacement Therapy
Start date: 1996-01-01
End date: 2002-01-01
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Premarin
Indication: Oestrogen Replacement Therapy
Prempro
Dosage: unknown
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1996-01-01
End date: 1998-01-01
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-29
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Premarin
Indication: Hormone Replacement Therapy
Prempro
Indication: Hormone Replacement Therapy
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a physician from United States on 2007-10-29
Patient: female, weighing 58.6 kg (128.9 pounds)
Adverse reactions / side effects: Breast Cancer Metastatic
Adverse event resulted in: hospitalization
Suspect drug(s):
Premarin (Conjugated Estrogens)
Other drugs received by patient: Remicade; Synthroid
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-29
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Cycrin
Dosage: unknown
Indication: Hormone Replacement Therapy
Premarin
Dosage: unknown
Indication: Oestrogen Replacement Therapy
Premphase 14 / 14
Dosage: unknown
Indication: Hormone Replacement Therapy
Prempro
Dosage: unknown
Indication: Hormone Replacement Therapy
Unspecified Estrogen Replacement Therapy
Dosage: unknown
Indication: Oestrogen Replacement Therapy
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a lawyer from United States on 2007-10-29
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Adverse event resulted in: death
Suspect drug(s):
Medroxyprogesterone Acetate
Dosage: unknown
Indication: Hormone Replacement Therapy
Start date: 2001-04-09
End date: 2002-07-26
Premarin
Dosage: unknown
Indication: Oestrogen Replacement Therapy
Start date: 2001-04-25
End date: 2002-08-07
Premphase 14 / 14
Dosage: unknown
Indication: Hormone Replacement Therapy
Start date: 2001-02-01
End date: 2001-04-09
Prometrium
Dosage: unknown
Indication: Hormone Replacement Therapy
Start date: 2000-12-01
End date: 2000-12-15
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-29
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Conjugated Estrogens
Cycrin
Dosage: unknown
Indication: Hormone Replacement Therapy
Estrace
Estratest
Dosage: unknown
Indication: Hormone Replacement Therapy
Medroxyprogesterone Acetate
Dosage: unknown
Indication: Hormone Replacement Therapy
Premarin
Dosage: unknown
Indication: Oestrogen Replacement Therapy
Premphase 14 / 14
Dosage: unknown
Indication: Hormone Replacement Therapy
Prempro
Dosage: unknown
Indication: Hormone Replacement Therapy
Provera
Dosage: unknown
Indication: Hormone Replacement Therapy
Unspecified Estrogen Replacement Therapy
Dosage: unknown
Indication: Oestrogen Replacement Therapy
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-29
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Adverse event resulted in: hospitalization
Suspect drug(s):
Estratest
Medroxyprogesterone
Premarin
Prempro
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-29
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic, Depression
Suspect drug(s):
Premarin (Conjugated Estrogens)
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-26
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Adverse event resulted in: hospitalization
Suspect drug(s):
Premarin
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a lawyer from United States on 2007-10-26
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Premarin
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a lawyer from United States on 2007-10-24
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Adverse event resulted in: hospitalization
Suspect drug(s):
Premarin
Premphase 14 / 14
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-24
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic, Myocardial Infarction
Suspect drug(s):
Premarin
Dosage: unspecified daily
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1993-02-08
End date: 1996-01-01
Prempro
Dosage: unspecified daily
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1996-12-04
End date: 2002-05-09
Provera
Dosage: unspecified daily
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1993-02-08
End date: 1996-01-01
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-24
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Premarin
Prempro
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-24
Patient: female, weighing 77.2 kg (169.8 pounds)
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Cycrin
Dosage: unspecified
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1993-01-01
End date: 2000-01-01
Estratest
Dosage: unspecified
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1993-01-01
End date: 2000-01-01
Estrogen NOS
Medroxyprogesterone Acetate
Dosage: unspecified
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1993-01-01
End date: 2000-01-01
Premarin
Dosage: unspecified
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1993-01-01
End date: 2000-01-01
Prempro
Dosage: unspecified
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1993-01-01
End date: 2000-01-01
Provera
Dosage: unspecified
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1993-01-01
End date: 2000-01-01
Page 1 Next >>
|
